Aggett Peter J
Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire, Preston PR1 2HE, UK.
Novartis Found Symp. 2007;282:46-53; discussion 53-8, 212-8. doi: 10.1002/9780470319444.ch4.
Claims are used to support public health advocacy and marketing. Their evidence base is variable. Claims are made on (i) nutrient content, (ii) comparative merits, (iii) health benefits, and (iv) medical benefits. Experience with therapeutic agents has aided the development of recommendations for the substantiation of health claims for foods and food components, with which dietary supplements would be included. An EU Concerted Activity, Functional Food Science in Europe, suggested that such claims should be based on the general outcomes of 'enhanced function' and 'reduced risk of disease'. A further EU Concerted Activity, The Process for the Assessment of Scientific Support for Claims on Foods, proposed that the evidence base should provide: a characterization of the food or food component to which the claimed effect is attributed; human data, primarily from intervention studies that represent the target populations for the claim; a dose-response relationship: evidence of allowing for confounders including lifestyle, consumption patterns, background diet and food matrix; an appropriate duration for the study; a measure of compliance; and have adequate statistical power to test the hypothesis. When ideal endpoints are not easily accessible for measurement, validated and quality assured markers of the intermediate or final outcomes could be used, as long as their relationship is well characterized. Overall, the totality and coherence of published and unpublished evidence should be considered. Assessments for substantiation need expert judgement, weighting of the strength of the claim, and intelligent use of the criteria applied on an individual basis with respect both to gaps in knowledge and to any need for new knowledge and data.
声明用于支持公共卫生宣传和营销。其证据基础参差不齐。声明涉及以下方面:(i)营养成分,(ii)比较优势,(iii)健康益处,以及(iv)医学益处。治疗药物的经验有助于制定关于食品和食品成分健康声明 substantiation 的建议,膳食补充剂也将包括在内。欧盟的一项协同活动“欧洲功能食品科学”表明,此类声明应基于“功能增强”和“疾病风险降低”的总体结果。欧盟的另一项协同活动“食品声明科学支持评估程序”提议,证据基础应提供:对声称效果所归因的食品或食品成分的特征描述;主要来自针对声明目标人群的干预研究的人体数据;剂量反应关系:考虑包括生活方式、消费模式、背景饮食和食物基质等混杂因素的证据;研究的适当持续时间;依从性的衡量标准;以及有足够的统计能力来检验假设。当理想的终点不易测量时,只要其关系得到充分表征,可使用经过验证且质量有保证的中间或最终结果标志物。总体而言,应考虑已发表和未发表证据的完整性和连贯性。 substantiation 的评估需要专家判断、对声明强度的权衡,以及根据个体情况明智地使用标准,同时考虑知识差距和对新知识及数据的任何需求。